1 Secondary hyperparathyroidism (SHPT): Assessing the educational support requirements for nurses across Europe A joint EDTNA/ERCA & Amgen (Europe) GmbH.

1

Secondary hyperparathyroidism (SHPT): Assessing the educational support requirements for nurses across EuropeA joint EDTNA/ERCA & Amgen (Europe) GmbH Project

Andrey Gurevich, MD PhDEuropean Development Medical DirectorAmgen (Europe) GmbH

MN-IHQ-AMG-355-2013-July-NP

2

Who is Amgen?

Neupogen®

launched

Expansion toEurope

Expansion to new therapeuticareas (bone)

1990s Tomorrow

Ultra rapid DNAsequencing

InduciblePluripotentstem cells

Gene therapy

Personalized medicines

2000-Today

Strong growth inproduct portfolio

Acquisitions

Global expansion

New modalities

CV and Neuroscience research efforts

1980

Amgen

established

Gene for erythropoietin cloned

1983

First major therapy, EPOGEN®, approved by FDA

1989

3

SHPT as a complication ofchronic kidney disease (CKD)

● Adding to the burden of CKD, is the development of SHPT ● A common complication manifested due to elevated

parathyroid hormone (PTH) levels, as well as calcium and phosphate disturbances

● A vicious cycle of decreased renal function, vitamin D deficiency and impaired mineral metabolism

● SHPT arises in most patients during the progressionof CKD

● Associated manifestations include: renal osteodystrophy, extraskeletal calcification and CVD disease, resulting in increased mortality

● The aim of treatment in secondary hyperparathyroidism isto manage levels of phosphate, PTH and calcium, and in turn reduce the associated clinically important complications

Melanie S et al. J Manag Care Pharm 2007; 13(5): 397-411.

4

The key role of nurses in managing patients with SHPT

Nurses provide care that meets a wide variety of

physical, social and psychological needs for their

CKD and SHPT patients

Patients feed back to nurses on their physical and social

condition

Education and support

5

Determining what educational support is needed

● The EDTNA/ERCA is developing a Nephrology Nurse Education Survey,in association with Amgen (Europe) GmbH, via an unrestricted grant

● The survey aims to understand the professional educational needs of the nephrology nurse in the management of SHPT

● The results will help to provide recommendations on how to improve the focus and quality of education given to nurses in this area

● Activities, such as an advisory board, have already been undertaken to enhance understanding in this area

6

Survey overview

● Selected centres across Europe, starting in Autumn 2013

● Strictly confidential and non-promotional online survey covering the following topics:

Background and nephrology experience

General knowledge of SHPT

Laboratory values and reaching targets

Therapies and adherence

Patient management and side effects

General training and education

7

A sample question

How often do you typically ask your patients about side effects that might be associated with their secondary hyperparathyroidism therapy?

A. AnnuallyB. About once every 3-12 monthsC. About once every 1-2 monthsD. Every monthE. Every visit

8

A sample question

What, in your experience, do you find to be the most challenging aspect of Secondary Hyperparathyroidism management? Select all that apply

• Explaining the disease and treatment to the patient at the point of diagnosis• Patient counselling and on-going support• Conducting regular testing, deciding upon regularity and nature of tests

required for each patient (either alone or with a consultant physician) … etc …

• Other

9

A sample question

What format of educational support would you find most valuable in helping you to support patients with Secondary Hyperparathyroidism? Select all that apply

• Educational training meetings • Online educational training meetings• Distance learning materials (hard copy packs)• Online interactive distance learning modules • Practical toolkits

… etc…• Newsletter and case study series written by nurses and experts

10

The results

Results of the survey will be published and used as a springboard for future educational

themes, materials and learning goals!

11

Thank you!